Applications:
Ingredient(s): Poly L Lactide, Polyethylene Glycol Excipient
Dosage Form: Tablet
Category: Controlled & Modified Release
Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades
Applications:
Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients
Dosage Form: Tablet
Category: Controlled & Modified Release
Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.
Applications:
Ingredient(s): Poly L Lactide
Dosage Form: Injectable / Parenteral, Tablet
Category: Controlled & Modified Release, Parenteral
Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group
Applications:
Ingredient(s): Poly DL Lactide
Dosage Form: Injectable / Parenteral, Tablet
Category: Controlled & Modified Release, Parenteral
Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group
Applications:
Ingredient(s): Poly DL Lactide co Glycolide
Dosage Form: Injectable / Parenteral, Tablet
Category: Controlled & Modified Release, Parenteral
Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.